Tag | Content |
---|
EnhancerAtlas ID | HS092-26947 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr21:39616040-39618210 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr21:39617621-39617639 | GAAAGGAAAGAAAGAAAG | + | 6.03 | EWSR1-FLI1 | MA0149.1 | chr21:39617516-39617534 | GAAAGAAAGAAAGGAGGG | + | 6.09 | EWSR1-FLI1 | MA0149.1 | chr21:39617543-39617561 | GAGAGGAAGGAAGGGAAG | + | 6.25 | EWSR1-FLI1 | MA0149.1 | chr21:39617650-39617668 | GAAAGGAAGGAAGGAGAA | + | 6.46 | EWSR1-FLI1 | MA0149.1 | chr21:39617520-39617538 | GAAAGAAAGGAGGGAAGG | + | 6.98 | EWSR1-FLI1 | MA0149.1 | chr21:39617528-39617546 | GGAGGGAAGGAAGGAGAG | + | 7.58 | EWSR1-FLI1 | MA0149.1 | chr21:39617524-39617542 | GAAAGGAGGGAAGGAAGG | + | 8.69 | GLI2 | MA0734.2 | chr21:39617787-39617802 | AGACCACCCACAAAG | + | 7.02 | GLIS3 | MA0737.1 | chr21:39617788-39617802 | GACCACCCACAAAG | + | 6.26 | HNF1A | MA0046.2 | chr21:39618019-39618034 | AATTAATAATTAAAT | + | 6.58 | IRF1 | MA0050.2 | chr21:39617639-39617660 | AGAGAGAAAGAGAAAGGAAGG | - | 6.44 | ZNF263 | MA0528.1 | chr21:39617544-39617565 | AGAGGAAGGAAGGGAAGGGAA | + | 6.25 | ZNF263 | MA0528.1 | chr21:39617545-39617566 | GAGGAAGGAAGGGAAGGGAAA | + | 6.2 | ZNF263 | MA0528.1 | chr21:39617659-39617680 | GAAGGAGAAAGAGAATGAAAG | + | 6.36 | ZNF263 | MA0528.1 | chr21:39617537-39617558 | GAAGGAGAGAGGAAGGAAGGG | + | 6.45 | ZNF263 | MA0528.1 | chr21:39617533-39617554 | GAAGGAAGGAGAGAGGAAGGA | + | 6.94 | ZNF263 | MA0528.1 | chr21:39617525-39617546 | AAAGGAGGGAAGGAAGGAGAG | + | 6.99 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_09241 | chr21:39616014-39619090 | CD14 | SE_45623 | chr21:39615784-39618542 | Osteoblasts | SE_51700 | chr21:39615831-39618527 | Skeletal_Muscle_Myoblast | SE_55658 | chr21:39611717-39618807 | u87 | SE_63489 | chr21:39615519-39618707 | HSMM | SE_67472 | chr21:39611717-39618807 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr21 | 39616081 | 39616344 | chr21 | 39616792 | 39617335 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I038244 | chr21 | 39615930 | 39618220 |
|
Enhancer Sequence | ATTTTTTTTT TGTCTTTGTG ACTATCTTGT TTATACAAAC TGAACCTGAG ACAAAGCCGC 60 TAGTGACTGC TTTTTGTGGT TAAACTGGTT TCGAACCCAC CAAAGTCTAG AAGAGGGAAA 120 GAAAGAATTG TACCAGATTT GATGTGTTTT GTGTAACGTA AGCCAGATTG TACCTCCTTC 180 TCTCTCTCCC AGGTCTGTAT ACAACTTAGG ACCAAGAGGT GGACTTTGGT GTCTTAGTTC 240 AAGCTCTAAA AATACCAGGG AAGCAGGGAC CACGACACAT CCCAGGCTTG GTGCAGAAAC 300 CTGACCTGAA TTGGACCTTA AGATCAGAAT ATAGATCTAT TGTCTTTCCT CACCTGGCTG 360 TTACCAAACT AACTTCCGCA TCTCCTGGGA GTGCTTTCTA TTTCATCCAG GCAGTGCCCT 420 TATCTGATCT GGAGTGGGTT TATCTCTGGG AGAGCTATTG AAGTGCCTGA CAGGAGAGGA 480 CACTAAGAGT ACCTCCAGTC TCCAACTGCC TCCTCCGGCA GAACTGAGCA AGTCCTAACC 540 ATGCCAAAAA CATCATTATC TCTGGTTCCA TCTTAGTCCC TGCACACCCT AGGATTCAAG 600 GACTCAAGTA AGTTGGGGAG GGGAACATCT TTTCACCCCT GGAAAACCTT GTCTCCTCCC 660 AAGCCCTGGG AGGGGAGAAC TGCTGCTAAT GAGATGCTGG TAGTTAGTCT TGTAATTTTT 720 ACAGTATTAT CTGCAGAATG AATGACTACC AGCAGGTACT CTGAATCTCT TTTCTTTCTA 780 ATAAGATGTA ATCAACGAAC CAGATTGTGG CCTTGGAGCT GACCAAAGGA TCAGCTAAAG 840 GAATTGGACA CATCCTGAGC TAGTTAACAC ATGGGTATTG TCGGTCTAAG ATGCTCTTTA 900 GGGGCTAGTG ACTCATTCAT GATGTGCAGG AAATGGCACA GACACCTCCA TGACCACAGA 960 AGGTTTCTAC AGGCGCCGTC ATCACAGGGT CTACAAACAG AAGGAAGTCA GAGAGAGAGG 1020 CTCAGGGGAA GGCAAGGCGG GGCTGGAGAC CTGGATTCTA CGTCGGAGTT TACCGCATCC 1080 TGGTTCTATT CCCAAAGTCC TCTCTGTGTG GCCATATGCC TGATTCTCAG CCTGGCTTCA 1140 TTCCAGTCAT CTCAGGATCT TACAAACAAC ATTGATGTCC AGGCCCCACC CCAGACCAAT 1200 GAAATCAGAA TCTCTTGGAC ATTAAAAAAA AAAATGAGTG ATTCTTTCTG GGTGATTCTA 1260 ATATGTGGTC AGGGTTGAGG CCACTGCTTT ACTTCATTAC ATCATGACAC TAAAAATACT 1320 ACTGGAAAGA AAAAAGGAGG GCTACCATCT GCCTTCCAAT CTCTTCAGCT GGGAACCTCT 1380 TCATAAGACT GTATCTGAAA CCAGGATACG AGATCCTTAT AAGTAATTCC ATTTATAATA 1440 ACAAAGAAAG AAAAGAAAGA AAGAAAGAGA GAGAGAGAAA GAAAGAAAGG AGGGAAGGAA 1500 GGAGAGAGGA AGGAAGGGAA GGGAAAGAGA GACAGAGAAA GGAAAGAAGA AAGAAAGAAG 1560 GAAAGGGAAG AAAGAAAGAA GGAAAGGAAA GAAAGAAAGA GAGAGAAAGA GAAAGGAAGG 1620 AAGGAGAAAG AGAATGAAAG GTGTTTACAG CTGGAAATCA AACAGAACTT TGCCTGACAC 1680 ATGTTCATTT TTGGCCATTT TTGCCTTTTT TGTGGTGTGA ACCATTAGTT CAGCCCAGTT 1740 AACCCTGAGA CCACCCACAA AGACTGAATT CAGAGGTGGC TGTCCAGTAC AGTGATTCAA 1800 GGTGAGGCCT GTGAAGTGAG ATCAAGATTT GAATTTCTGC TTCTCAGTTC ACCAACTATT 1860 TGACCTTGGG CAAGTGACTT AATTCAAGAC TTAGTTTTAT CATTTATAAA GTAAGAAGAA 1920 TAATACCTGT CTTACATACT CTGATTTGTT GATATGATAG TCAATATGCT ATAAGAATAA 1980 ATTAATAATT AAATGACACG GTAGACATAA GGCATTTAAA TCTAATTCCT GATCCACAGC 2040 AAACCTTCAA CAAATAGCAG CTGTTATCAT CAGAGCTAAA ACGAATCATG TATCTAGGCT 2100 AGGGTCTGGT TTCTTTGCTG TTTTGGATAA TGGCTTAGGA ATAAGAATAA TGCCCACTGA 2160 AGAAGTCTTG 2170
|